Table 4.
Identification of factors associated with a clinical response in patients with irritable bowel syndrome (IBS) infected with Dientamoeba fragilis (N = 22)*
| Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|
| OR | 95% CI | P value | P value | Removed in step no. | |
| Age | 1.10 | 0.96–1.26 | 0.19 | 0.98 | 1 |
| Gender, female | 0.18 | 0.012–2.42 | 0.20 | 0.19 | 8 |
| IBS subtype | |||||
| IBS-C | 2.06 | 0.31–13.58 | 0.45 | 0.76 | 3 |
| IBS-D | 1.13 | 0.18–6.94 | 0.90 | 0.44 | 6 |
| D. fragilis mono-infection | 3.75 | 0.54–26 | 0.18 | 0.75 | 4 |
| Co-infected with Blastocystis | 0.19 | 0.02–1.99 | 0.17 | 0.16 | 9 |
| Eradicated of all parasites | 0.67 | 0.11–4.20 | 0.67 | 0.09 | 7 |
| Eradicated of Blastocystis | < 0.001 | 0.001 < × < 999.999 | 0.96 | 0.88 | 2 |
| Eradicated of D. fragilis | 1.25 | 0.18–8.87 | 0.82 | 0.75 | 5 |
*
OR = odds ratio; CI = confidence interval.